University of Pennsylvania and Syracuse University scientists have discovered that a hindbrain-derived peptide, octadecaneuropeptide (ODN), can suppress appetite and improve glucose regulation without ...

Researchers identified a combination of two existing cancer drugs, letrozole and irinotecan, that reversed Alzheimer’s ...

Summary: New research uncovers how tau pathology spreads and damages synapses in progressive supranuclear palsy (PSP). Using ...

Alzheimer’s disease remains one of medicine’s toughest challenges, affecting millions and costing trillions of dollars ...

Clock genes are a set of genes known to contribute to the regulation of the human body's internal 24-hour cycle, also known ...

With so few Alzheimer’s drugs available, repurposing medications approved for other conditions could be the key to tackling ...

Why does one child with autism speak fluently but struggle socially, while another barely talks yet shows remarkable pattern ...

A finger-prick blood test reliably measures neurofilament light, enabling remote monitoring that could revolutionize ...

Funding will be specifically used to accelerate the clinical development of urcosimod (formerly called OK-101).

GLP-1 blockbusters like semaglutide and tirzepatide are widely used for diabetes and weight loss but come with some nasty ...

The University of Virginia School of Medicine's Harald Sontheimer, PhD, and Stanford's Michelle Monje, MD, PhD, have received ...

Peer-reviewed publication in Annals of Clinical and Translational Neurology highlights the use of the MSA Atrophy Index developed to diagnose and track disease progression in Multiple System Atrophy - ...